Table 2

 Recipient data (preoperative and intraoperative)

Series NoAgeDiagnosisDate of surgeryPreoperative medicationDonor eye NoType of surgeryCourse of surgeryType and No of sutureSubcutaneous injectionCulture from media in OT
CHED, congenital hereditary endothelial dystrophy; PK, penetrating keratoplasty; OT, operating theatre; poly B, polymyxin B.
15/FCHED28.6.030.3% ciprofloxacin four times daily1Optical PK (figs 1, 2)Uneventful10.0 MFN 16, interruptedDexamethasone and gentamicinPseudomonas sensitive to poly B
217/FKeratoconus30.8.030.3% ciprofloxacin four times daily2DLKUneventful10.0 MFN 16, interruptedDexamethasone and gentamicinNot sent
346/MLeucomatous corneal opacity7.11.030.3% ciprofloxacin four times daily3Optical PKUneventful10.0 MFN 16, interruptedDexamethasone and gentamicinNot sent
465/FFuchs’ endothelial dystrophy7.4.040.3% ciprofloxacin four times daily4*Triple procedureUneventful10.0 MFN 16, interruptedDexamethasone and gentamicinPseudomonas sensitive to poly B
539/FPost-pterygium surgery, scleral melting7.4.040.3% ciprofloxacin four times daily4*Scleral patch graftUneventful10.0 MFN interrupted 5, 8-0 Vicryl scleral suture 6Dexamethasone and gentamicinPseudomonas sensitive to poly B
650/MLeucomatous corneal opacity21.4.040.3% ciprofloxacin four times daily5ATriple procedureUneventful10-0 MFN 16 interruptedDexamethasone and gentamicinNot sent
755/MLeucomatous corneal opacity21.4.040.3% ciprofloxacin four times daily5BOptical PKUneventful10.0 MFN 16, interruptedDexamethasone and gentamicinNot sent